{"name":"iOnctura","slug":"ionctura","ticker":"","exchange":"","domain":"ionctura.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPNWZvN2lVTllVV3pVdnlrY2xVZzF2c0pTdG1DUGgzMzR2Y2JjV3JOeGF3MHdrYUFsc0Q4UXdHenY0cmFwMnhMSDR2eTRwSnoteUVwSU9kNTF5cHhWNmdaMnIwNmk0TnU3cGtMR0RWQnJoRGY0WlV1bHVvV2p5NjRmQkk4dXA1czg4bjE3Wk4yODAwbmRtRWx5X04zUHdWdDBFcngtSFJ0bThkM2FiSElfRjVHSndnM0x3N0ZjdnlMTm0?oc=5","date":"2026-01-09","type":"pipeline","source":"PR Newswire","summary":"iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference - PR Newswire","headline":"iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOQVJvZmZXNVRWT0lwYlpTTGVZVmFlNXR6a0liSjRHOTBXUHFad18tWVNFNTRteXRSbEEtQ3R0aFp3LUg3YXE3eFd5OXd4UXBacm1vV3BWQVJMUUJtekJJc21EQXZsUUZkbElXcmpBVjZabnV4aXB4Y21LZDJBM1VnMWJxMk9tQnBJVlllVHlLYWxtUUJiUWNnYnpnMzdhSEFueFE?oc=5","date":"2025-12-09","type":"pipeline","source":"startupticker.ch","summary":"Promising progress for therapies against critical medical needs - startupticker.ch","headline":"Promising progress for therapies against critical medical needs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQTWE5bUN3RXk0aDJSUmFRSVFJYkdYemFGc21xY2VKYWZvYzBGZUtfejQwdXdsaWc4NVhYRHBhaWt6SDJILTJwTi1aamRqeHZkUkhMNThnbzViU3FFelNuRktzYWpjOHNMNHJkRzYyTjdmekh1U2paeVNfa25hOHNCeGVvY3U2OURreXdhMHVwclNKM1ZWR2k2Q1BLRHd2QTdxcXNQWkRsdW5fd3dfOGkyUXpvZk9JRGNwWV9HNjNnMTlObWlDZU1WV25EN29XMGN6UTJQUzV2XzloQ2FuX203b1RDVGotdGpYb3FnOFN3M25jR25ITkRmd2cxY3o3dGx1cFN5WFJFb0xXdFQ0OEU3VFZsZUxCTXdoYjVvVFh0TUxRQWpuQXVONU9YQURJWlJF?oc=5","date":"2025-09-23","type":"trial","source":"GlobeNewswire","summary":"TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ - GlobeNewswire","headline":"TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1FLVRqdGd5R3NYWGdkZWxkeGRGXzhTcVQtVm9RMjVZWVB2LTZFaTI2cnNZc1J6N0YxV1VRbUNDa2dUQzRlT3ItVlpIZ0pFdWU0Q2ZNaUY3QXZTYmZ6ZC1IMg?oc=5","date":"2025-06-17","type":"pipeline","source":"PharmaTimes","summary":"Steven Sciuto - PharmaTimes","headline":"Steven Sciuto","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNVURBSHg3X0ptcFBHQ0l3ZTlJTThleWhpd25xMk9KRmJ6YVJzd3VOOEVtZkJHUDRhbUtVVGY3R1hrUnNLcWp4Zy0tWHcySGlDbXNWYlNFbWk1N05XeUhCdzl4STBWQzRya0JuX2EwV1RCOXB1U29lQmlidU1qODVWcGFWVGk2U3VFSGdNR25BTGNWTVdfMFdwSkl3?oc=5","date":"2025-03-21","type":"regulatory","source":"Fierce Biotech","summary":"Former FDA deputy joins AI biotech's board—Chutes & Ladders - Fierce Biotech","headline":"Former FDA deputy joins AI biotech's board—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOczJlZUo2dWRFSHZ1dlpzZlRBUzJrRlBOaGtOUFRPNTA0cVJtcDVzSG1LMmRNdWJkejZIbERUWktHRFBhbEptRkJ1c3pQa3hHS2ZRS2kxOTFtY2s2NU5JVW9UdmpRd0V4cUZFa3pLRXBsdVJZdV9VWTloaGpVWVBFaHA2ckItejVJQVJjRGtNQXFQQ2pwdzhGWUUtT3plQQ?oc=5","date":"2024-12-11","type":"pipeline","source":"PharmaTimes","summary":"iOnctura achieves new clinical milestones in uveal melanoma therapy - PharmaTimes","headline":"iOnctura achieves new clinical milestones in uveal melanoma therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNdW5TcHM0NkJZSUI2bEduUzV2MGkzUFNxZXRUTkJma3VMbzFrNHQ0WEc5TmlxcEdXSUc2LXI1amFDQ2E5MHQ3b3dXcEM2LTRxUzdBOGVNbk5LNmVkb0lIb3FpMEJwNUtVRXk0VmtiQ0lHSDF6c29nallCUVBKRk5Cank2ejRkVnpyRHlTNFAyZVpjUURiYUhvU0lnenVkVkRISGFhUWd2WHgwWFowVWFJV3daNA?oc=5","date":"2024-06-20","type":"trial","source":"Clinical Trials Arena","summary":"iOnctura raises nearly $86m in Series B to fund Phase II cancer trials - Clinical Trials Arena","headline":"iOnctura raises nearly $86m in Series B to fund Phase II cancer trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNb3VtOU5MLUZnWVNYQXZTcXhXaVRGVkVXYU13MGl3Y3JBVWc3OS1jYlVLZGFQSTdQMVprVnlCV0Q2ZUlMVWNZWkhXa1ZLVnRSdGpxbGRYMTdWajNjbGNpU0Nza2l2QmxyQ1g2Mng4QkYydENEMmp2TXpGMjl6UnFBR3pTbmN1ajVQSHczQlY5Vml5bmE5aUFZZktPNXFkNjV4eWdkVkJiQzZpM3UzLXVJc2toNA?oc=5","date":"2024-06-20","type":"pipeline","source":"Fierce Biotech","summary":"With iOnctura and Yellowstone, Syncona adds two cancer biotechs to growing portfolio - Fierce Biotech","headline":"With iOnctura and Yellowstone, Syncona adds two cancer biotechs to growing portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNZ0lzeUxtMC1SUXA1T3BtdUVqdTdQRUF3ZF81NlNqeGZQNFpqYkQ5TFZvYkhVWG50TXhiRWVJZFhwS2daRHRqcUUwSkFPZ1NFYVFxQ1NsSWhISjRQMWM3b2tYOEVJNkh6TmlJd0Rta1RwS3V5WXhDNUxWMGZEZWxxUWdIeHNoQ0dCUzdkNXFMU3BwOFItMlM4RjVB?oc=5","date":"2023-12-04","type":"pipeline","source":"pharmaphorum","summary":"Uveal melanoma: A new generation of therapies offers hope for patients - pharmaphorum","headline":"Uveal melanoma: A new generation of therapies offers hope for patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTk1YcE1pSmlIZnltQjZ0dHBuVlh3cTM1X2JiTE1iekh6N2RKNEwyMVNYOS1jYkZPWVFLdDc4QjRWZ2IxcmowQi1PZ1hKamxwZWZxUDVEb0RfMkR4RTE2RWpvUXFia0pqUThXU0w3OWV6MWxrcF9kQUhQTGsyUG90M2I0Q0pmcDBo?oc=5","date":"2023-08-08","type":"pipeline","source":"pharmaphorum","summary":"Realising the potential of autotaxin inhibition in cancer - pharmaphorum","headline":"Realising the potential of autotaxin inhibition in cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOaUZzM1JMZXdTVGluWENxaUE3RU9MaHBlcUVtUmtyTkFKTkdyY0J2YVEtT0JFQ0NsQi1ZODlsRnhockZvQ19uSTZtbU4zSGVPNzFqTkw4MnQxUVlVUmlfQ3NHejBHS1VRRm45M0drc2MyR2RVWVRsQnhXNk84NDdaMW93UGc?oc=5","date":"2022-12-20","type":"pipeline","source":"Labiotech.eu","summary":"iOnctura raises €17.5M for pancreatic cancer therapy - Labiotech.eu","headline":"iOnctura raises €17.5M for pancreatic cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1WYUJ4R2w1RkdlNE9KR0V1ZFBValZTWXlzTW5aYTdrLWp0azhMOUdfeXJJSHZXRThKVm96cU9xUElDNEFZNVdtdXhrZE9rUHpzZTkyWlM0LXVxS2VDWHUtZXNRYkd2c0VQZmZpYVlnTVR6cjlJaG1iUw?oc=5","date":"2020-08-13","type":"pipeline","source":"Pharmaceutical Technology","summary":"Linking cancer and fibrosis: iOnctura raises €20.1m in a Series A round - Pharmaceutical Technology","headline":"Linking cancer and fibrosis: iOnctura raises €20.1m in a Series A round","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}